Table 1.
Demographics and baseline characteristics of patients infected with COVID-19.
| All patient (n = 154) | moderate group (n = 49) | severe group (n = 61) | critical group (n = 44) | p value | |
|---|---|---|---|---|---|
| Age (y) | 64 ± 14 | 63 ± 13 | 63 ± 14 | 65 ± 15 | NS |
| Gender (male/Female) | 84/70 | 26/23 | 34/27 | 24/20 | NS |
| Chronic medical illness | |||||
| Any comorbidity | 91 (59.09%) | 28 (57.14%) | 31 (50.82%) | 32 (72.73%) | NS |
| Diabetes | 19 (12.34%) | 5 (10.20%) | 4 (6.56%) | 10 (22.73%) | 0.039 |
| Hypertension | 48 (31.17%) | 13 (26.53%) | 16 (26.23%) | 19 (43.18%) | NS |
| Cardiovascular and cerebrovascular diseases | 30 (19.48%) | 13 (26.53%) | 2 (3.28%) | 15 (34.09%) | <0.001 |
| Chronic liver disease | 5 (3.25%) | 2 (4.08%) | 2 (3.28%) | 1 (2.27%) | NS |
| Respiratory systemdisease | 15 (9.74%) | 2 (4.08%) | 6 (9.84%) | 7 (15.91%) | NS |
| Malignant tumor | 3 (1.95%) | 0 (0.00%) | 2 (3.28%) | 1 (2.27%) | NS |
| Clinical outcome | |||||
| Remained in hospital | 41 (26.62%) | 16 (32.65%) | 13 (21.31%) | 12 (27.27%) | NS |
| Transferred | 10 (6.49%) | 6 (12.24%) | 4 (6.56%) | 0 (0.00%) | NS |
| Discharged | 76 (49.35%) | 24 (48.98%) | 42 (68.85%) | 10 (22.73%) | <0.001 |
| Died | 24 (15.58%) | 2 (4.08%) | 2 (3.28%) | 20 (45.45%) | <0.001 |
Note: Three patients lost case information and data are mean ± SD, n/n, or n (%). p values comparing moderate group, severe group and critical group are from χ2 test or Fisher’s exact test, or Variance analysis, P < 0.05 was defined as statistically significant.